A potentially
promising new treatment strategy involves targeting the epithelial growth factor receptor (EGFR), which is frequently overexpressed in cervical cancer.
Not exact matches
As a consequence, targeting alt - EJ players emerged as a
new promising strategy for the
treatment of HR - deficient tumors.